Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
OtherIUPHAR Compendium of Voltage-Gated Ion Channels 2005

International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels

Aguan D. Wei, George A. Gutman, Richard Aldrich, K. George Chandy, Stephan Grissmer and Heike Wulff
Pharmacological Reviews December 2005, 57 (4) 463-472; DOI: https://doi.org/10.1124/pr.57.4.9
Aguan D. Wei
Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri (A.D.W.); Departments of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Molecular and Cellular Physiology Department, Stanford University, Stanford, California (R.A.); Department of Medical Pharmacology and Toxicology, University of California, Davis, Davis, California (H.W.); and Department of Applied Physiology, University Ulm, Ulm, Germany (S.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George A. Gutman
Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri (A.D.W.); Departments of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Molecular and Cellular Physiology Department, Stanford University, Stanford, California (R.A.); Department of Medical Pharmacology and Toxicology, University of California, Davis, Davis, California (H.W.); and Department of Applied Physiology, University Ulm, Ulm, Germany (S.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Aldrich
Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri (A.D.W.); Departments of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Molecular and Cellular Physiology Department, Stanford University, Stanford, California (R.A.); Department of Medical Pharmacology and Toxicology, University of California, Davis, Davis, California (H.W.); and Department of Applied Physiology, University Ulm, Ulm, Germany (S.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. George Chandy
Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri (A.D.W.); Departments of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Molecular and Cellular Physiology Department, Stanford University, Stanford, California (R.A.); Department of Medical Pharmacology and Toxicology, University of California, Davis, Davis, California (H.W.); and Department of Applied Physiology, University Ulm, Ulm, Germany (S.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Grissmer
Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri (A.D.W.); Departments of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Molecular and Cellular Physiology Department, Stanford University, Stanford, California (R.A.); Department of Medical Pharmacology and Toxicology, University of California, Davis, Davis, California (H.W.); and Department of Applied Physiology, University Ulm, Ulm, Germany (S.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heike Wulff
Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri (A.D.W.); Departments of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Molecular and Cellular Physiology Department, Stanford University, Stanford, California (R.A.); Department of Medical Pharmacology and Toxicology, University of California, Davis, Davis, California (H.W.); and Department of Applied Physiology, University Ulm, Ulm, Germany (S.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Introduction

The second major group of six/seven transmembrane potassium-selective channels consists of the KCa channels (for reviews, see Lingle, 2002; Magleby, 2003; Moczydlowski, 2004; Stocker, 2004; Cox, 2005), and Table 1 shows the International Union of Pharmacology (IUPHAR1) names of the members of this group together with their HUGO Gene Nomenclature Committee (HGNC) designations and other commonly used names. The phylogenetic trees in Fig. 1 illustrate the fact that these channels form two well defined but only distantly related groups.

View this table:
  • View inline
  • View popup
TABLE 1

KCa channels IUPHAR names of the members of the KCa group of potassium channels are shown, together with their HGNC designations and other commonly used names.

One of these groups (Fig. 1A) includes the three “small-conductance” KCa channels (KCa2.1, 2.2, and 2.3) (Kohler et al., 1996) and the “intermediate-conductance” channel KCa3.1 (Ishii et al., 1997; Joiner et al., 1997). These channels are voltage-insensitive and are activated by low concentrations of internal Ca2+ (<1.0 μM), in contrast to KCa1.1 (KCNMA1, Slo1), which is activated by both voltage and internal Ca2+. The three small-conductance KCa channels are sensitive to block by apamin (100 pM–10 nM), which distinguishes them from all other KCa channels. Both small- and intermediate-conductance KCa channels play important roles in many processes involving Ca2+-dependent signaling in both electrically excitable and nonexcitable cells. They do not bind Ca2+ directly but rather detect Ca2+ by virtue of calmodulin, which is constitutively bound to the C-terminal region (Xia et al., 1998; Fanger et al., 1999). Binding of calcium to this calmodulin results in conformational changes that are in turn responsible for channel gating (Schumacher et al., 2001).

The tree shown in Fig. 1B illustrates the sequence relationships within the second group of KCa channels, which includes KCa1.1 (Slo or Slo1), KCa4.1 (Slack or Slo2.2), KCa4.2 (Slick or Slo2.1), and KCa5.1 (Slo3). KCa1.1 has been extensively studied in the brain, cochlea, and muscle, and alternate splicing of its mRNA is known to produce considerable functional diversity (Weiger et al., 2002; Faber and Sah, 2003). Unlike the KCa2 and KCa3 channels, binding of calcium by KCa1.1 is not dependent on its association with calmodulin but is thought to be mediated by at least three divalent cation binding sites in the cytoplasmic carboxyl domain of each channel subunit. Two independent high-affinity Ca2+ binding sites are formed by a negatively charged segment in the distal carboxyl terminal portion, termed the “calcium bowl” (Schreiber and Salkoff, 1997) and within the first RCK domain encoded by the proximal C-terminal portion (Bao et al., 2002; Xia et al., 2002). A third low-affinity divalent cation binding site is also found in the first RCK domain (Shi et al., 2002), which contributes to activation by Mg2+ and Ca2+ at high concentrations (>1 mM).

The three other members of this group, KCa4.1, 4.2, and 5.2 (Joiner et al., 1997; Schreiber et al., 1998; Yuan et al., 2003), were all included in the KCa nomenclature since they all are clearly members of this structurally related group of genes. However, much more is now known about the functional properties of the members of this gene family than was known when these names were assigned several years ago, and this presents a possible conundrum for a nomenclature based on functional rather than structural similarity. Unlike the founding member KCa1.1, which is in fact activated by internal Ca2+, none of the other members of this group seems to be similarly Ca2+-activated. In fact, for the most part, these three are insensitive to internal Ca2+. KCa4.2 and KCa4.1 are activated by internal Na+ and Cl- (Yuan et al., 2003), and KCa5.1 is activated by internal alkalization (OH-) (Schreiber et al., 1998). Therefore, although they are structurally related to KCa1.1, these three channels cannot correctly be described as “calcium-activated” channels based on functional criteria. This may be a subject for discussion among researchers in this field and those bodies responsible for standardizing gene nomenclature.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Phylogenetic tree for KCa channels. A, KCa2/3 group. B, KCa1/4/5 group. Amino acid sequence alignments and phylogenetic analysis for these two groups of four human KCa channels were generated as described in the legend for Fig. 1 of “International of Union of Pharmacology LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels.” No new channels have been added to these topologies since they appeared in the earlier edition of this compendium. IUPHAR and HGNC names of the genes are shown together with other commonly used names and their chromosomal localization.

Tables 2, 3, 4, 5, 6, 7, 8, 9 present the KCa1.1 through KCa 5.1 channels.

View this table:
  • View inline
  • View popup
TABLE 2

KCa1.1 channels

View this table:
  • View inline
  • View popup
TABLE 3

KCa2.1 channels

View this table:
  • View inline
  • View popup
TABLE 4

KCa2.2 channels

View this table:
  • View inline
  • View popup
TABLE 5

KCa2.3 channels

View this table:
  • View inline
  • View popup
TABLE 6

KCa3.1 channels

View this table:
  • View inline
  • View popup
TABLE 7

KCa4.1 channels

View this table:
  • View inline
  • View popup
TABLE 8

KCa4.2 channels

View this table:
  • View inline
  • View popup
TABLE 9

KCa5.1 channels

Footnotes

  • ↵1 Abbreviations: IUPHAR, International Union of Pharmacology; HGNC, HUGO Gene Nomenclature Committee; RCK, regulator of K+ conductance.

  • A.D.W. and H.W. serve as the Subcommittee on KCa Channels of the Nomenclature Committee of the International Union of Pharmacology.

  • Article, publication date, and citation information can be found at http://pharmrev.aspetjournals.org.

  • doi:10.1124/pr.57.4.9.

  • The American Society for Pharmacology and Experimental Therapeutics

References

  1. ↵
    Bao L, Rapin AM, Holmstrand EC, and Cox DH (2002) Elimination of the BKCa channel's high-affinity Ca2+ sensitivity. J Gen Physiol 120: 173-189.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Cox DH (2005) The BKCa channel's Ca2+-binding sites, multiple sites, multiple ions. J Gen Physiol 125: 253-255.
    OpenUrlFREE Full Text
  3. ↵
    Faber ESL and Sah P (2003) Calcium-activated potassium channels: multiple contributions to neuronal function. Neuroscientist 9: 181-194.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Fanger CM, Ghanshani S, Logsdon NJ, Rauer H, Kalman K, Zhou J, Beckingham K, Chandy KG, Cahalan MD, and Aiyar J (1999) Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J Biol Chem 274: 5746-5754.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, and Maylie J (1997) A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA 94: 11651-11656.
    OpenUrlAbstract/FREE Full Text
  6. Joiner WJ, Tang MD, Wang LY, Dworetzky SI, Boissard CG, Gan L, Gribkoff VK, and Kaczmarek LK (1998) Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits. Nat Neurosci 1: 462-469.
    OpenUrlCrossRefPubMed
  7. ↵
    Joiner WJ, Wang LY, Tang MD, and Kaczmarek LK (1997) hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc Natl Acad Sci USA 94: 11013-11018.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Kohler M, Hirschberg B, Bond CT, Kinzie JM, Marrion NV, Maylie J, and Adelman JP (1996) Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273: 1709-1714.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Lingle CJ (2002) Setting the stage for molecular dissection of the regulatory components of BK channels. J Gen Physiol 120: 261-265.
    OpenUrlFREE Full Text
  10. ↵
    Magleby KL (2003) Gating mechanism of BK (Slo1) channels: so near, yet so far. J Gen Physiol 121: 81-96.
    OpenUrlFREE Full Text
  11. ↵
    Moczydlowski EG (2004) BK channel news: full coverage on the calcium bowl. J Gen Physiol 123: 471-473.
    OpenUrlFREE Full Text
  12. ↵
    Schreiber M and Salkoff L (1997) A novel calcium-sensing domain in the BK channel. Biophys J 73: 1355-1363.
    OpenUrlCrossRefPubMed
  13. ↵
    Schreiber M, Wei A, Yuan A, Gaut J, Saito M, and Salkoff L (1998) Slo3, a novel pH-sensitive K+ channel from mammalian spermatocytes. J Biol Chem 273: 3509-3516.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Schumacher MA, Rivard AF, Bachinger HP, and Adelman JP (2001) Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin. Nature (Lond) 410: 1120-1124.
    OpenUrlCrossRefPubMed
  15. ↵
    Shi J, Krishnamoorthy G, Yang Y, Hu L, Chaturvedi N, Harilal D, Qin J, and Cui J (2002) Mechanism of magnesium activation of calcium-activated potassium channels. Nature (Lond) 418: 876-880.
    OpenUrlCrossRefPubMed
  16. ↵
    Stocker M (2004) Ca2+-activated K+ channels: molecular determinants and function of the SK family. Nat Rev Neurosci 5: 758-770.
    OpenUrlCrossRefPubMed
  17. ↵
    Weiger TM, Hermann A, and Levitan IB (2002) Modulation of calcium-activated potassium channels. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 188: 79-87.
    OpenUrlCrossRefPubMed
  18. ↵
    Xia XM, Fakler B, Rivard A, Wayman G, Johnson-Pais T, Keen JE, Ishii T, Hirschberg B, Bond CT, Lutsenko S, et al. (1998) Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature (Lond) 395: 503-507.
    OpenUrlCrossRefPubMed
  19. ↵
    Xia XM, Zeng X, and Lingle CJ (2002) Multiple regulatory sites in large-conductance calcium-activated potassium channels. Nature (Lond) 418: 880-884.
    OpenUrlCrossRefPubMed
  20. ↵
    Yuan A, Santi CM, Wei A, Wang ZW, Pollak K, Nonet M, Kaczmarek L, Crowder CM, and Salkoff L (2003) The sodium-activated potassium channel is encoded by a member of the Slo gene family. Neuron 37: 765-773.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Pharmacological Reviews: 57 (4)
Pharmacological Reviews
Vol. 57, Issue 4
1 Dec 2005
  • Table of Contents
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherIUPHAR Compendium of Voltage-Gated Ion Channels 2005

International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels

Aguan D. Wei, George A. Gutman, Richard Aldrich, K. George Chandy, Stephan Grissmer and Heike Wulff
Pharmacological Reviews December 1, 2005, 57 (4) 463-472; DOI: https://doi.org/10.1124/pr.57.4.9

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherIUPHAR Compendium of Voltage-Gated Ion Channels 2005

International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels

Aguan D. Wei, George A. Gutman, Richard Aldrich, K. George Chandy, Stephan Grissmer and Heike Wulff
Pharmacological Reviews December 1, 2005, 57 (4) 463-472; DOI: https://doi.org/10.1124/pr.57.4.9
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels
  • International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels
  • International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels
Show more IUPHAR Compendium of Voltage-Gated Ion Channels 2005

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics